Physician profile
Amber Lopez
NPI 1275156622
$1,030.24
in general payments reported to CMS, 2019-2025
16 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $312 · 2022: $88.30 · 2023: $104 · 2024: $265 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $217.36 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $195.08 | 2024 | |
| Abiomed | $140.59 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $82.80 | 2021 | |
| Abbott Laboratories | $81.60 | 2021 | |
| Amgen INC. | $68.91 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $47.37 | 2021 | |
| Abbvie INC. | $39.52 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.08 | 2021-2022 | |
| Innovation Technologies INC | $26.94 | 2025 | Irrisept |
| Edwards Lifesciences Corporation | $19.54 | 2022 | |
| Bioventus LLC | $18.41 | 2025 | Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $17.66 | 2021 | |
| Philips North America LLC | $15.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.44 | 2023 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.